Although no vaccines have been launched, Pharmaprojects reports nine drugs in active development, including GlaxoSmithKline's tetravalent vaccine, currently in Phase II trials.Even before the disaster struck dengue fever was a disease that had no major discovery effort directed to new treatments despite figures suggesting it was long overdue.